Document is current
Any future updates will be listed below
-
Authors
Darwish, Mona
Passarell, Julie
Maxwell, Kelly
Youakim, James M.
Bradley, Heather
Bishop, Kathie M.
-
Funding
Funding for this research was provided by:
ACADIA Pharmaceuticals
- License Information
-
More Information
Article History
Received: 22 August 2024
Accepted: 25 October 2024
First Online: 18 December 2024
Declarations
:
: Mona Darwish, James M Youakim, and Heather Bradley are employees of and hold stock options in Acadia Pharmaceuticals Inc. Kathie M Bishop was an employee of Acadia when this work was conducted. Julie Passarell and Kelly Maxwell are employees of and hold stock in Simulations Plus.
: The results presented in this manuscript are based on published studies. All procedures performed in those studies involving human participants were conducted in accordance with the ethical standards of the local institutional review boards for each site and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consent was obtained by the parent or legal guardian on behalf of the study participants included in the phase 2 studies and the phase 3 LAVENDER study.
